• Je něco špatně v tomto záznamu ?

Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study

M. Hromadka, J. Baxa, J. Seidlerova, R. Miklik, D. Rajdl, V. Sudova, D. Suchy, R. Rokyta

. 2021 ; 10 (22) : . [pub] 20211118

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001279

Grantová podpora
00669806 MH CZ - DRO (Faculty Hospital in Pilsen - FNPl)

INTRODUCTION AND OBJECTIVES: Cardiac involvement in systemic sclerosis (SSc) patients affects mortality. Cardiac magnetic resonance (CMR) is capable of detecting structural changes, including diffuse myocardial fibrosis that may develop over time. Our aim was to evaluate myocardial structure and function changes using CMR in patients with SSc without known cardiac disease during a 5-year follow-up and find possible correlations with selected biomarkers. METHODS: A total of 25 patients underwent baseline and follow-up CMR examinations according to a pre-specified protocol. Standard biochemistry, five biomarkers (hsTnI, NT-proBNP, galectin-3, sST2, and GDF-15), and disease-specific functional parameters enabling the classification of disease severity were also measured. RESULTS: After five years, no patient suffered from manifest heart disease. Mean extracellular volume (ECV) and T1 mapping values did not change significantly (p ≥ 0.073). However, individual increases in native T1 time and ECV correlated with increased galectin-3 serum levels (r = 0.56; p = 0.0050, and r = 0.71; p = 0.0001, respectively). The progression of skin involvement assessed using the Rodnan skin score and a decrease in the diffusing capacity of the lungs were associated with increased GDF-15 values (r = 0.63; p = 0.0009, and r = -0.51; p = 0.011, respectively). CONCLUSIONS: During the 5-year follow-up, there was no new onset of heart disease observed in patients with SSc. However, in some patients, CMR detected progression of sub-clinical myocardial fibrosis that significantly correlated with elevated galectin-3 levels. GDF-15 values were found to be associated with disease severity progression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001279
003      
CZ-PrNML
005      
20220112153543.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm10225364 $2 doi
035    __
$a (PubMed)34830647
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hromadka, Milan $u Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Alej Svobody 80, 304 60 Pilsen, Czech Republic
245    10
$a Myocardial Involvement Detected Using Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis: A Prospective Observational Study / $c M. Hromadka, J. Baxa, J. Seidlerova, R. Miklik, D. Rajdl, V. Sudova, D. Suchy, R. Rokyta
520    9_
$a INTRODUCTION AND OBJECTIVES: Cardiac involvement in systemic sclerosis (SSc) patients affects mortality. Cardiac magnetic resonance (CMR) is capable of detecting structural changes, including diffuse myocardial fibrosis that may develop over time. Our aim was to evaluate myocardial structure and function changes using CMR in patients with SSc without known cardiac disease during a 5-year follow-up and find possible correlations with selected biomarkers. METHODS: A total of 25 patients underwent baseline and follow-up CMR examinations according to a pre-specified protocol. Standard biochemistry, five biomarkers (hsTnI, NT-proBNP, galectin-3, sST2, and GDF-15), and disease-specific functional parameters enabling the classification of disease severity were also measured. RESULTS: After five years, no patient suffered from manifest heart disease. Mean extracellular volume (ECV) and T1 mapping values did not change significantly (p ≥ 0.073). However, individual increases in native T1 time and ECV correlated with increased galectin-3 serum levels (r = 0.56; p = 0.0050, and r = 0.71; p = 0.0001, respectively). The progression of skin involvement assessed using the Rodnan skin score and a decrease in the diffusing capacity of the lungs were associated with increased GDF-15 values (r = 0.63; p = 0.0009, and r = -0.51; p = 0.011, respectively). CONCLUSIONS: During the 5-year follow-up, there was no new onset of heart disease observed in patients with SSc. However, in some patients, CMR detected progression of sub-clinical myocardial fibrosis that significantly correlated with elevated galectin-3 levels. GDF-15 values were found to be associated with disease severity progression.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Baxa, Jan $u Department of Imaging Methods, University Hospital and Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 304 60 Pilsen, Czech Republic
700    1_
$a Seidlerova, Jitka $u Internal Department II, University Hospital and Faculty of Medicine in Pilsen, Charles University, Edvarda Benese 1128/13, 305 99 Pilsen, Czech Republic
700    1_
$a Miklik, Roman $u Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Alej Svobody 80, 304 60 Pilsen, Czech Republic
700    1_
$a Rajdl, Dan $u Department of Clinical Biochemistry and Hematology, University Hospital and Faculty of Medicine in Pilsen, Alej Svobody 80, 304 60 Pilsen, Czech Republic
700    1_
$a Sudova, Vendula $u Department of Clinical Biochemistry and Hematology, University Hospital and Faculty of Medicine in Pilsen, Alej Svobody 80, 304 60 Pilsen, Czech Republic
700    1_
$a Suchy, David $u Department of Clinical Pharmacology, Rheumatology, University Hospital and Faculty of Medicine in Pilsen, Charles University, Edvarda Benese 1128/13, 305 99 Pilsen, Czech Republic
700    1_
$a Rokyta, Richard $u Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen and Faculty Hospital, Charles University, Alej Svobody 80, 304 60 Pilsen, Czech Republic
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 10, č. 22 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34830647 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153539 $b ABA008
999    __
$a ind $b bmc $g 1745428 $s 1152426
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 22 $e 20211118 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a 00669806 $p MH CZ - DRO (Faculty Hospital in Pilsen - FNPl)
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...